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1Introduction
Introduction
Background
In 2006, the Centers for Disease Control and Prevention (CDC) published the Revised 
Recommendations for HIV Testing of Adults, Adolescents and Pregnant Women in Health Care Settings 
(Branson, Handsfield, et al. 2006). CDC recommends routine HIV screening in health care 
settings using an opt-out approach in order to increase the number of patients being screened for 
HIV infection, detect HIV infection earlier and link patients with unrecognized HIV infection to 
clinical and prevention services.
To reduce barriers to HIV screening and make HIV tests similar to other types of health screenings, 
CDC recommends that separate written consent and prevention counseling should not be required 
with diagnostic testing or screening programs.
The implementation of routine HIV screening requires a change in practice for most health care 
settings and may involve new types of testing procedures, such as point-of-care rapid HIV tests 
as opposed to laboratory-based HIV testing procedures. As part of implementation, health care 
settings may collect a range of statistics about their 
testing program, such as the number of patients screened, 
percentage of preliminary positive tests, proportion of 
those with preliminary positive results undergoing 
confirmatory testing, and percent of confirmed positives 
linked successfully to care. These statistics, while 
important, do not provide information on patient or 
provider perspectives about routine HIV screening in 
health care settings, including patient satisfaction with 
and acceptance of HIV screening.
Purpose
Understanding patient and provider perspectives is an integral component of evaluating clinical 
programs to improve clinical services. The purpose of this evaluation toolkit is to offer a package 
of evaluation materials that can be used to determine the effect that expanded HIV screening 
activities has on patient attitudes toward and accepting HIV testing. Health care organizations 
and providers can use the results from the evaluation toolkit for a number of different purposes:
 • To evaluate patient experiences and satisfaction with routine HIV screening.
 • To inform customer satisfaction and quality assurance initiatives related to the implementation 
of a new service.
 • To examine progress with the implementation of routine HIV screening and identify areas 
for quality improvement by conducting periodic evaluations.
 • To identify concerns of patients and providers that may pose barriers to acceptance of HIV 
screening or may hinder effective implementation.
CDC defines opt-out 
screening as: “Performing 
HIV screening after 
notifying the patient that  
1) the test will be performed and  
2) the patient may elect to decline or 
defer testing. Assent is inferred 
unless the patient declines testing” 
[Branson, Handsfield, et al. 2006
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Overview of the Questionnaires
The Evaluation Toolkit includes a patient questionnaire and a health care provider and staff 
questionnaire. This section provides information on each of the questionnaires and how and when 
to administer them to both patients and staff.
Patient Questionnaire
The patient questionnaire provides a mechanism to obtain patients’ perspectives about routine 
HIV testing in various health care settings including, but not limited to, emergency departments 
and public or private clinics. This tool will help assess patient preferences and satisfaction with and 
attitudes towards CDC-recommended practice, including opt-out screening, pre-test information 
and different methods of receiving test results.
The patient questionnaire was developed through a review of the literature on patient acceptability 
of routine HIV testing, including evaluation of previously published patient satisfaction tools 
(Dietz, Ablah, et al. 2008; Steward, Herek, et al. 2008) and consultation with health care providers 
implementing routine HIV testing. The questionnaire underwent cognitive testing with 4 patients 
visiting a public clinic to assess clarity and comprehension of the questionnaire items. The 
questionnaire was then revised and pilot tested among 272 patients in three types of health care 
settings: a publicly funded health clinic, a private clinic providing reproductive health services and 
an emergency department. Data from the pilot testing were used to assess the instrument’s validity, 
identify additional question revisions, and inform the content of the toolkit.
The patient questionnaire is designed to be offered to adolescent and adult patients receiving health 
care services at a time when routine HIV screening is available at the facility, irrespective of whether 
they received an HIV test. The questionnaire is available in English (Appendix B1) and Spanish 
(Appendix B2).
The anonymous, self-administered, 25-item patient questionnaire takes about 20 minutes to 
complete and includes a series of questions related to:
 • Demographics
 • Preferred HIV pre-test information, consent and testing procedures
 • Experiences and satisfaction with HIV testing procedures
 • Barriers and facilitators to testing
 • HIV-related stigma and discrimination
 • Perception of HIV risk behaviors
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Questionnaire for Health care Providers and Staff  
(Provider Questionnaire)
The questionnaire for health care providers and staff (provider questionnaire) is designed to be 
offered in conjunction with the patient questionnaire. It should be completed by health care 
providers and staff who are directly involved in routine HIV testing as well as those who are 
working in the clinical unit or practice setting where routine testing is being implemented.
Information from providers is intended to supplement and provide insights about data collected 
using the patient questionnaire. It also allows comparisons between patient and provider perspectives 
about routine HIV testing. By assessing both patients and health care providers, comprehensive 
information can be generated to evaluate program progress and patient/customer satisfaction and 
identify areas of strength and those needing improvement.
The provider questionnaire was developed through review of the literature and was also informed 
by discussions with and presentations by health care providers involved in the implementation of 
routine HIV testing (Royce, Walter, et al. 2001; Brown 2007; Burke, Sepkowitz, et al. 2007; White 
2007). Items were created to complement the key issues assessed in the patient questionnaire. The 
final provider questionnaire was field tested among nine providers in a public clinic and reviewed 
by health care providers from a variety of clinical settings.
The anonymous 26-item, self-administered provider questionnaire takes about 10–15 minutes to 
complete and asks providers for their perspectives on the following topics:
 • Health care provider roles related to routine HIV testing
 • Role of routine HIV testing in health care
 • Voluntary testing and consent
 • Adequacy of patient education
 • Confidentiality
 • HIV-related stigma
 • Barriers and facilitators to routine HIV testing
Getting Started
The following sections describe how to plan for an evaluation and provide guidance and procedures 
for implementing questionnaires and data collection activities, analyzing the data, generating 
reports and using the evaluation results to improve clinical services. The appendices contain the 
tools necessary to complete evaluation activities, including an evaluation planning tool, the model 
patient and provider questionnaires and information on comparing similar items between the 
patient and provider questionnaires.
Before implementing an evaluation, it is helpful to first develop a simple evaluation plan that 
describes the purpose of the evaluation, establishes a time frame, and summarizes inclusion criteria 
and procedures for recruitment and consent to participate in the questionnaire. An evaluation plan 
template can be found in Appendix A.
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When developing your evaluation plan, the following areas should be considered:
Identifying Staff and Fiscal Resources
Identify the key providers or staff who will help implement the evaluation. Although self-
completed questionnaires and other components of the toolkit are designed to minimize staff time 
and resources required for the evaluation, personnel costs should be considered. Additionally, any 
direct costs (e.g. the cost of photocopying the questionnaires) should also be factored in to the 
total cost of the evaluation (HRSA 2011).
Timeline for Evaluation Activities
The timeline for the evaluation will depend upon several factors, including the time needed for 
Institutional Review Board (IRB) review and approvals (if applicable, see next section), as well as 
your target sample size and daily patient volume. Plan to budget 1–2 months to determine your 
target sample size, make any modifications to the model patient or provider questionnaires, meet 
with staff to discuss the evaluation, and submit any necessary paperwork to the IRB.
Data collection can range from a few days to a few weeks, depending on the goals of the evaluation 
and available staff time. For instance, a health care setting that is interested in recruiting patients 
across several providers and during different times of the month will need to estimate a longer 
timeframe for data collection than a health care setting that plans to gather a convenience sample 
of patients for a one week period. When the patient questionnaire tool was piloted using a 
convenience sample method in three busy health care settings, data collection took an average of 3 
days, yielding a range of 65 to 112 completed surveys per location. More information on sampling 
can be found in the section “Determining Sampling Method and Sample Size”.
Once data collection is complete, anticipate another 2–3 weeks to conduct data analysis. Data 
analysis can be facilitated by using the Microsoft Office ACCESS® database that accompanies 
this toolkit. More information on this database can be found in the section ‘Data Analysis and 
Developing Reports’.
Obtaining Required Approvals from Administrators and Institutional 
Review Boards (IRBs)
Requirements for IRB review and approval may vary across health care settings and according 
to how the evaluation data will be used. Even if you intend to use data for internal evaluation 
or quality improvement, you are collecting data directly from patients and health care providers. 
It is best to check with your IRB to determine what type of review, if any, is required. Your IRB 
administrator will be able to provide you with an estimated timeline of how long IRB review will 
take for your evaluation.
Garnering Staff Support
Discuss the planned evaluation and questionnaires in staff meetings and other venues to be sure 
that physicians, nurses, nurse managers, counselors, and others with direct patient contact know 
about the project. Posters or informational fliers can also be used to encourage staff interest and 
keep them informed.
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Adapting the Questionnaires
The patient and provider questionnaires have been designed to explore a number of topics pertinent 
to routine HIV screening programs. Some examples of how the patient questionnaire can be 
adapted to fit the context and needs of your particular health care setting are listed below:
 • A clinic may modify the introductory paragraph in the questionnaire to fit with the purpose 
and design of their evaluation and local consent requirements.
 • Questions are grouped so that specific parts of the questionnaire, such as sections on HIV 
risk behaviors or stigma and discrimination, can be edited easily or removed.
 • Sites may also want to adapt items in the questionnaire to reflect local testing procedures by 
modifying certain items or sections, such as:
 » Including the name or description of patient education materials referred to in items 5 
and 6.
 » Revising specific items in the questionnaire to fit with opt-in screening (see example 
below).
Examples of possible adaptations in settings that use opt-in screening
Item# Patient Questionnaire Possible Adaptation (shown in bold)
3a.
I have a chance to give my permission to be 
tested in writing
I am required to give my permission to be 
tested in writing
3d.
I don’t have to ask for an HIV test because 
HIV testing is a regular part of health care
I am offered an HIV test as a regular part of 
health care
3e. I am given a chance to say “no” to testing I am given a chance to say “yes” to testing
The provider questionnaire should be reviewed so items can be modified as needed to fit with your 
health care setting as shown in the following examples:
Edit Item B12 to specify your health care setting:
B12. I am concerned that routine HIV testing will have a negative effect on patients’ 
opinions about our [health care facility/clinic/emergency department/practice].
Edit item C7 to refer to follow-up procedures in your health care setting:
C7. Patients who test HIV positive receive appropriate referrals for follow up.
For sites that also provide HIV care, this question may be edited to replace “referrals” with 
“appointments”.
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Determining Sampling Method and Sample Size
Due to time and resource constraints, it is often necessary to conduct surveys among a subset, 
or sample, of a population, rather than the entire population. Before implementing the Patient 
Questionnaire, you’ll need to decide how you want to sample your patient population and how 
many patients will be administered the questionnaire. For the Provider Questionnaire, it will most 
likely be feasible to survey all staff members involved in routine HIV testing.
There are two primary methods of sampling:
1. Convenience Sampling
The simplest method is a convenience sample. With this method, persons are approached to 
participate in the survey based upon opportunity (Adamchak, Bond, et al. 2000). For instance, a 
clinic may offer the survey to all patients seen at the clinic during a one week period. Although 
convenience sampling is relatively easy to implement, a key disadvantage is that the patients 
sampled may not be representative of your entire patient population (HRSA 2011). This will limit 
the ability to apply conclusions about patient satisfaction to your entire patient population.
2. Random Sampling
A more complex, but scientifically more rigorous, sampling method is random sampling. In random 
sampling, each patient has an equal chance of being selected to participate in the survey (HRSA 
2011). This method requires creating a ‘sampling frame’ or a set of identifiers that represents every 
patient in the population. For a primary care clinic for example, the sampling frame might include 
all active patients in the clinic. For settings with less easily identified populations, a sampling frame 
might be constructed in multiple ‘stages’ or levels based on date and time of visits. For example, in 
a recent study of HIV testing in an emergency department, a sampling frame was created based 
on multiple stages:
Stage 1: Selecting dates in a month
Stage 2: Selecting a shift or shifts within the dates selected
Stage 3: Selecting persons within a shift.
A variation of random sampling, stratified sampling, can be used if you are interested in measuring 
a particular characteristic for each subpopulation (e.g., comparing patient satisfaction by race 
or ethnicity) (HRSA 2011). This is particularly helpful when the numbers of patients in some 
subpopulations are much smaller than others or the numbers of total participants will be relatively 
small. In stratified sampling, a population of interest is first divided into subgroups, and then a 
random sampling from each subgroup is taken. The advantage of random sampling is the ability 
to obtain data from a large enough number of participants in each subpopulation to make valid 
conclusions about your entire patient population based upon your sample. A disadvantage of this 
method is that it is more time consuming and complex to implement. If your setting is interested 
in using random sampling it may be important to consult with a statistician or sampling specialist 
to identify a sampling strategy that will work for your setting.
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Sample Size
While the number of people you include in your survey — your sample size — may be largely a 
result of your situation (for example how many patients your clinic sees and how many people in 
the clinic are available to recruit patients to complete the survey), you may also wish to consider 
setting the number of patients you wish to sample based on an estimate you wish to obtain. In 
general, the larger your sample, the more precisely you will be able to estimate a characteristic of 
your clinic population. For example, if 75% of the people you survey answer that they have had an 
HIV test, and you interview 100 people, your confidence limits around that estimate will be 65% 
to 83%. If you had interviewed 200 people with the same percent of people responding that they 
had had an HIV test your confidence limits would be from 68% to 81%.
If you also wish to compare a characteristic or questionnaire response between groups of patients 
in your clinic, you will need to make sure that you have enough patients in each group to estimate 
the characteristic you are interested in comparing. The smaller the difference you wish to find, the 
more people you will need to interview to find a statistically significant difference. For example, if 
you think that one group in your clinic has a testing rate of 75% and another has a testing rate of 
only 50%, you would need to interview at least 66 people from each group. If you think that one 
group in your clinic has a testing rate of 75% and the other has a testing rate of 60%, you would 
need to interview 165 people from each group.
For more information on determining sampling methods and sample size,  
see HRSA’s Health Center Patient Satisfaction Survey website: 
http://bphc.hrsa.gov/policiesregulations/performancemeasures/patientsurvey/satisfactionsurvey.html
You will also want to consider which patients to approach for the survey. For instance, you may 
want to offer the survey to patients 18 years of age or older, or only those patients who can fill out 
the questionnaire in English or Spanish. You may also want to exclude patients based on the nature 
of their visit or the severity of their medical condition at the time they are seen by the provider.
Recruitment Scripts
Develop a standard script that can be used to explain the survey both to patients and health 
care providers/staff. The script should describe the purpose of the survey, emphasize that the 
questionnaire is voluntary and anonymous, explain that participants can skip questions they don’t 
want to answer, and explain how questionnaire results will be used to improve clinical services 
(HRSA 2011). Posters or informational fliers can be used to publicize the survey to patients and 
facilitate recruitment.
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Consent and Confidentiality
Information about consent and confidentiality is included at the beginning of each questionnaire. 
Patients and health care providers indicate their consent by completing and returning the 
questionnaire. Additional consent procedures may be required depending on local IRB regulations, 
particularly if you are including patients under 18 years of age.
When preparing questionnaires, consent and confidentiality statements should be reviewed and 
modified to meet the requirements of your practice setting or institution.
For more information on evaluation planning, see the CDC’s Framework for  
Program Evaluation in Public Health:  
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4811a1.htm
Administering the Questionnaire
The patient questionnaire includes sensitive questions about a number of topics, including HIV 
testing and HIV risk behaviors. Staff responsible for administering the questionnaire should receive 
training so that they can answer patient questions appropriately and address patient concerns. The 
following section provides guidance on administering the Patient and Provider questionnaires.
1. Make sure that the participant is comfortably seated in a location that assures privacy and 
confidentiality.
2. Do not collect identifying information about the participant; the questionnaires are meant 
to be anonymous.
3. Give the participant time to read the introductory script explaining the questionnaire and 
consent. If s/he agrees to participate, let him/her know how s/he can reach a staff member 
if questions or problems are encountered with the questionnaire.
Although staff members should be available to assist participants with the questionnaire, they 
should not provide assistance by ‘interpreting’ any questions for the participant; instruct the 
individual to answer as s/he understands a question.
4. Each questionnaire should be labeled with a unique identifier (ID):
 » Do not re-use any IDs.
 » Once the participant has received the questionnaire, the questionnaire form and ID 
number should not be reused if the participant decides not to complete it or only 
completes some of the items. Do not reassign the ID to another participant.
5. After the participant completes the questionnaire, store it in a secure place until it can be 
processed for data entry and analysis. Questionnaires that are returned blank or partially 
completed should also be stored, to keep record of the number of persons who were 
approached to take the survey and consented to participate, but did not complete the survey 
for whatever reason.
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Data Analysis and Developing Reports
To help make it easy to analyze patient questionnaire data, a Microsoft Office ACCESS® database 
has been developed that can be used for data entry and to generate automatic reports. A copy of 
the database and a corresponding Evaluation Toolkit Database User’s Manual can be obtained by 
sending an e-mail to the AIDS Education and Training Centers’ National Evaluation Center at : 
aetcnec@ucsf.edu
Data from the patient questionnaire are input into the database using a data entry module 
(Figure 1). Please see the Evaluation Toolkit Database User’s Manual for more information on how 
to input data into the database.
Figure 1: Data Entry Screen Sample
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Report Templates
Reporting resources and templates provided in the toolkit can be tailored to meet site-specific 
needs. Users may be interested in responses to the entire questionnaire but also may want to focus 
on individual items or groups of items related to a specific topic.
Figure 2 provides an example of the reporting function of the Evaluation Toolkit Database. Please 
see the Evaluation Toolkit Database User’s Manual for more information on how to run a report 
from the database.
Figure 2: Report Template Screen Sample
Reviewing Results from the Patient and Provider Questionnaires
The patient and provider questionnaires each address common issues related to the implementation 
of routine HIV screening. A table has been created to help you identify questions that correspond 
to specific issues, such as consent or confidentiality, and link questions on the patient questionnaire 
with those on the provider questionnaire (See Appendix D, Summary of Topics and Questionnaire 
Items).
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When examining results, it can be helpful to look at agreement and discrepancies between patients’ 
and providers’ responses to specific questions or groups of questions. The following table illustrates 
complementary questions on the Patient and Provider questionnaires:
Patient Questionnaire Questionnaire for Health care Providers and Staff
2c. I felt like I should take an HIV test. B6. Patients often feel like they have to accept routine HIV testing.
4a. I had a choice to take the test. B10. Routine HIV testing is voluntary; patients are able to decline screening.
If results indicate that patients are not concerned about feeling pressured to take the test, but 
providers agree with the statement that “patients often feel like they have to accept routine HIV 
testing”, the questionnaire results have identified a discrepancy in attitudes.
If the majority of patients report the statement “I had a choice to take the test” is definitely true 
or mostly true and the majority of providers strongly agree or agree that “routine HIV testing is 
voluntary; patients are able to decline screening”, the findings demonstrate agreement between 
patients’ and providers’ opinions about the voluntary nature of routine HIV testing in your health 
care setting.
Scoring and analysis of scales:
After the questionnaire is completed, each item may be analyzed separately or in some cases, 
individual responses that are considered part of a set or scale may be summed or summarized 
in some way to create a score for a group of items. Scale development and use is a large and 
much debated area of research. What follows is a discussion of some of the most common 
approaches used.
Analysis of individual items in a scale:
Although scale items are ordinal (ordered from one end of a spectrum of response to another), one 
cannot assume that each level is equidistant. An example of this is a 5-point scale of agreement 
(totally agree, somewhat agree, neither agree or disagree, somewhat disagree, totally disagree). In this 
example, the difference between strongly agree and agree is probably not the same difference as the 
difference between agree and neither agree or disagree. For this reason descriptive analyses often 
summarize the frequency of each category of response for each item.
If used as a predictor variable in statistical modeling, item responses may be treated as a categorical 
variable (i.e., no underlying numerical meaning). However, if there are multiple items of this type, 
or if the item will be used as an outcome variable, responses may be summarized by the median or 
mean of responses to an item or set of related items.
Another approach often used in analysis is to choose a cut point based either on theory or on 
the raw distribution of scores and create a dichotomous variable, that is, a variable with only 
two responses (e.g., agree/disagree), for use in analysis. For example, one might choose to create a 
variable that takes on a value of 1 if any category of agree is chosen and 0 otherwise.
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Analysis of scales:
Responses to several scale items may be summed to form a scale, providing that all questions use 
the same responses and each of the questions measure aspects of the same underlying construct. 
Use of a scale assumes that the scale approximates an interval scale (all levels are equidistant). This 
assumption is defensible for multiple items (e.g., 5 or more) under the Central Limit Theorem.
The appropriateness of combining scale items can be assessed by conducting factor analyses 
to assess whether items represent one or more underlying constructs (called latent variables). 
The internal consistency or reliability of the scale can be measured by calculating a Cronbach’s 
alpha. This statistic represents the degree to which items within the scale vary together.
Disseminating Questionnaire Results
The purpose of the evaluation will guide the use and dissemination of results from the patient 
and provider questionnaires. Insights about experiences, opinions, and acceptance of routine HIV 
testing may address questions and concerns about routine testing initiatives. In this way, results of 
the patient and provider questionnaires can be used to support practice change — including scale-
up of testing services to other units or settings within a health care organization.
Results may also point out areas needing additional follow-up through quality assurance initiatives 
or continuous quality improvement. If problems are identified, it can be helpful to develop 
possible strategies to address them and include these with the dissemination of results. There are a 
number of available resources clinical sites can use to address issues that are identified through the 
questionnaire, such as patient education brochures and implementation checklists (see information 
box, below). Findings from Patient and Provider Questionnaires can also be used in conjunction 
with other data (number screened, acceptance rates, etc.) to evaluate implementation goals and 
outcomes of routine HIV screening.
Patient education materials and clinical support tools can be found at the following 
organizations’ websites:
AIDS Education and Training Centers National Resource Center 
www.aidsetc.org ( click on “Testing” in the “Topics” drop down menu)
National Association of Community Health Centers  
http://www.nachc.com/hivmodel.cfm
Evaluation findings should be shared in an appropriate and timely manner to the staff and the 
rest of the clinical setting or organizations providing routine HIV testing services. This may be 
done in very simple ways, such as presentations at staff meetings and distribution of an evaluation 
summary to patients.
To learn more about strategies for disseminating evaluation results see: 
http://aetcnec.ucsf.edu/nec?page=eval-00-00
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Using Questionnaire Results for Quality Assurance and 
Continuous Quality Improvement (CQI)
Routine HIV testing programs use test-related and outcome indicators to periodically monitor 
and evaluate the implementation and quality of their program part of customer satisfaction or 
quality assurance/continuous quality improvement (CQI) programs.
Quality indicators may include the number of patients offered and accepting a routine HIV 
test, the number of tests performed, test results and patient referrals. The questionnaires in the 
evaluation toolkit offer an opportunity to supplement these objective indicators with measures 
reflecting patient and provider feedback. A number of items in the Patient Questionnaire directly 
ask clients about their experiences with routine HIV testing in the context of health care. These 
items are particularly useful as quality indicators because they can be analyzed and reported as part 
of CQI activities.
Quality indicator items in the Patient Questionnaire assess patients’ experiences with routine HIV 
testing with regard to whether testing was voluntary and private; the time required for testing 
and giving information about HIV; receipt of information; and overall satisfaction. Periodic 
quality assessments can be useful when trying to address issues or problems identified through a 
comprehensive evaluation or to assess the stability of quality over time, particularly if there have 
been changes in the staff involved in routine HIV testing. Note that when using a subset of items 
for periodic quality assessment, it may be important to conduct a small pilot test of the abbreviated 
questionnaire to confirm that the abbreviated questionnaire is understandable and to ensure the 
questionnaire doesn’t interrupt clinical flow.
In the context of quality assurance, sites may want to set targets for specific items. For example, 
sites may set a quality goal of having at least 95% of patients indicate that testing was voluntary. 
This would be met by having 95%–100% of the respondents who were tested for HIV respond 
that the following item was definitely true or mostly true:
4a. I had a choice to take the test
The following section lists patient-centered quality indicators and describes how to calculate them. 
It is important to consider how routine HIV screening procedures at your site may influence the 
outcomes for certain indicators, such as the number and proportion of patients offered testing or 
given materials to read.
Patient-Centered Quality Indicators for Routine HIV Testing
General patient-centered quality assurance (QA) indicators for performance of 
routine HIV testing
1. Number and proportion of patients tested/not tested for HIV [Item 1]
2. Number and proportion of patients who reported that they were not offered routine HIV 
testing [Item 1]
3. Number and proportion of patients who reported that they received material to read about 
HIV or HIV testing [Item 5]
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Denominators to be used in calculating proportion (percentages) for general quality assurance 
indicators:
 • Number of patients who responded to the item
Patient-centered quality assurance indicators for patients who indicated 
they were tested for HIV [Item 1=yes]
The number and proportion of patients who:
1. Didn’t know their result or how they would receive it [Item 1]
2. Agreed (definitely true or mostly true) that they had a choice to take the test [Item 4a]
3. Agreed (definitely true or mostly true) that their HIV test was done in private [Item 4b]
4. Were satisfied (definitely true or mostly true) with the time it took to receive their test results 
[Item 4c]
5. Received material to read about HIV or HIV testing [Item 5]
6. Agreed (definitely true or mostly true) they could understand the material they were given 
about taking an HIV test [Item 6a]
7. Agreed (definitely true or mostly true) that the materials they received explained how to get 
or give HIV [Item 6b]
8. Agreed (definitely true or mostly true) that they had a chance to ask questions about the 
materials they received [Item 6c]
9. Rated their experience with HIV testing today as Excellent or Very Good [Item 8].
Denominators to be used in calculating QA percentages for patients who were tested for HIV:
 • Number of patients who indicated they were tested [Item 1=Yes] and who responded to the 
item for the indicator.
Using CQI/QA Results
When sites are not meeting designated targets for quality indicators, clinical observations and 
input from health care providers can be useful in defining and addressing specific problems. 
In addition to staff meetings, the provider questionnaire may be useful in obtaining feedback from 
all staff.
The following websites offer information and resources about quality assurance and CQI 
for health care services:
National Association for Healthcare Quality (NAHQ): http://www.nahq.org/
The Institute for Healthcare Improvement (IHI):  
http://www.ihi.org/ihi#Institute%20for%20Health%20Care%20improvement
Agency for Healthcare Research and Quality: http://www.ahrq.gov/
National Quality Center (NQC): http://nationalqualitycenter.org/
15
Summary 
Summary
This guide was designed to provide health care settings with evaluation tools to determine the effect 
that expanded HIV screening activities has on patient attitudes toward and accepting HIV testing. 
These tools include step-by-step instructions on how to conduct an evaluation, model patient 
and provider questionnaires, and administrative tools to assist with data analysis and reporting. 
Materials have been developed so they can be used in their present form, or easily adapted to 
meet the needs of your specific health care setting. Through the use of these tools, it is hoped your 
health care setting can obtain information that can be used for a variety of purposes to improve 
and enhance clinical services for routine HIV screening.
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Appendix A — Evaluation Plan Template
(Adapted from Writing an Evaluation Plan by the AIDS Education and Training Centers National 
Evaluation Center, available at http://aetcnec.ucsf.edu/)
Introduction/Purpose: An introduction provides background information important to the 
evaluation, identifies the purpose and the goal of the evaluation, and provides a roadmap of the 
evaluation plan.
 • Evaluation Goal:
 » What does the evaluation strive to achieve?
 » What is the purpose of the evaluation?
 » How will the findings be used?
 • Evaluation Team
 » Who is your evaluation coordinator?
 » Who are the members of your evaluation team?
 • Evaluation Advisory Group (optional)
Background and Description of the Program and Program Logic Model: The program 
description ensures that stakeholders have a shared understanding of the program and identifies 
any unfounded assumptions and gaps.
 • Need
 » What problem does your program address?
 » What are the causes and consequences of the problem?
 » What is the magnitude of the problem?
 » What changes or trends impact the problem?
 • Context
 » What are the political, social and structural factors that affect your program or initiative?
 • Target Population
 » What are the characteristics of the population served by your program?
 • Program Objectives
 » What objectives have been set for your program?
 • Stage of Program Development
 » Is this a new program or initiative, or is it well-established?
 • Resources
 » What resources are available to conduct the program activities?
 • Activities
 » What are program staff doing to accomplish program objectives?
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 • Outputs
 » What are the direct and immediate results of program activities (materials produced, 
services delivered, etc.)?
 • Outcomes
 » What are the intended effects of the program activities?
Program Logic Model: A logic model is a graphic depiction of the program description
 • Arrows describe the links between resources, activities, outputs and outcomes
 • A logic model
 » Provides a sense of scope of your program
 » Ensures that systematic decisions are made about what is to be measured
 » Helps to identify and organize indicators
For an example of a logic model, please see: http://www.uwex.edu/ces/pdande/evaluation/
evallogicmodel.html
Defining Evaluation Questions
 • Evaluation questions should:
 » Be based on the needs of your setting
 » Be tied to program objectives and/or include program targets or standards
 » Address process or outcome measures
 » Be feasible to answer
 » Provide accurate results
Methods for Conducting the Evaluation 
 • Key Issues in Evaluation Design
 » Who is your target population?
 » When will you collect data?
 » What resources are available for conducting this evaluation?
 » What data do you already have or are collecting for another purpose that will be useful 
in this evaluation?
 • Once you have evaluation questions, indicators and standards can be identified, and data 
collected.
 • Indicators should:
 » Be visible, measurable signs of program performance
 » Be relevant, understandable and useful
 » Reflect program objectives, logic model and evaluation questions
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 • Program Standards and Targets from the workplan:
 » Reasonable expectations of program performance
 » Defines success
 » Benchmarks against which to measure performance
 • Data collection:
 » What methods will be used to collect data?
 » How often will the data be collected?
 » Who will collect the data?
 • Tips for Data Collection
 » Collect only the information you need
 » Make questionnaire easy to administer and use
 » Pilot test the tools before using them in the evaluation
 • Human Subjects Considerations
 • Evaluation Timeline
 » Ensures that all stakeholders are aware of what activities are occurring at any time
 » Helps to determine if your evaluation resources will be strained by too many activities 
happening at once
 • Data Management and Storage
 » Ensures confidentiality and data quality
Plan for Analysis
 • Once the data are collected, analysis and interpretation will help you understand what the 
findings mean for your program.
 • Anticipate your analysis
 • What analytic techniques will you use for each data collection method?
 • Who is responsible for analysis and interpretation of the data?
 • What conclusions will you be able to draw from your findings?
 • How will you involve stakeholders in the analysis?
Plan for Reporting and Dissemination:
 • Dissemination
 » What medium/ia will you use to disseminate findings?
 » Who is responsible for dissemination?
 • Use
 » How, where, and when will findings be used?
 » Who will act on the findings?
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Overall Tips
 • Start small — focus on one initiative or program component and limit the number of 
evaluation questions.
 • The more you plan your evaluation in advance, the easier it will be to write your report.
 • Be realistic in your assessment of resources; be realistic in your timeline.
 • Get feedback from others in the evaluation community.
Turning a Plan into a Report
 • Add a results section:
 » How many participants did you survey?
 » What were their characteristics (table)?
 » What were the results of the questionnaires?
 • Add a discussion section:
 » Are there alternative explanations for the results?
 » Are the results generalizable?
 » Are certain parts of the program better received by certain groups?
 » Are any results related to certain attitudes or other characteristics?
 » Were there unexpected results?
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Appendix B1 — Patient Questionnaire (English)
Questionnaire ID Number____________
Patient Questionnaire about HIV Testing (Flesch-Kincaid Grade Level: 4.9)
This survey is completely anonymous (your name will not be used) and your participation is 
voluntary. You don’t have to answer any questions that you don’t want to answer and can just skip 
these questions. Thank you for your time.
1 . Were you tested for HIV today?
  Yes
  No
If you DID NOT GET an HIV test today, why not? Check all that apply . 
  No one asked me about it
  I don’t think I am at risk for HIV infection
  I was recently tested for HIV
  I am already HIV positive
  I’m worried about confidentiality
  I don’t want to be tested at this center
  I’m afraid of finding out that I am HIV positive
  I’m afraid of the finger prick and/or needles
  Other (describe):_____________________________
If you DID GET an HIV test today, what was the result of your test?
  Negative
  Positive
  Preliminary Positive
  Invalid or indeterminate
  I will come back for the results at another visit.
  Someone is going to call me with the results.
  I don’t know
If your test result is negative, do you think you will take another HIV test in the future?
  Yes
  No
  I don’t know
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2 . How much did the following affect your decision to get an HIV test today?
Not at all A little
A moderate 
amount
Quite a lot A great deal
A. I was worried about learning the 
result of my HIV test. 1 2 3 4 5
B. I was worried someone else 
might learn about my test result. 1 2 3 4 5
C. I felt like I should take an HIV test. 1 2 3 4 5
D. I was worried about getting 
health insurance or life insurance 
if I learned I had HIV.
1 2 3 4 5
E. I did not know how long it would 
take to get an HIV test. 1 2 3 4 5
F. I did not know how long it would 
take to get my HIV test results back. 1 2 3 4 5
G. I was more worried about my 
other health issues today. 1 2 3 4 5
ABOUT HIV TESTING GENERALLY:
3 . For you, how important are the following procedures in HIV testing?
Not at all 
important
A little bit 
important
Moderately 
important
Quite 
important
Extremely 
important
A. I have a chance to give my 
permission to be tested in writing. 1 2 3 4 5
B. My HIV test is completely private. 1 2 3 4 5
C. My HIV test is free of charge. 1 2 3 4 5
D. I don’t have to ask for an HIV test 
because HIV testing is a regular 
part of health care.
1 2 3 4 5
E. I am given a chance to say “no” to 
testing. 1 2 3 4 5
F. I am able to receive my results 
the same day (today). 1 2 3 4 5
23
Appendix B1 — Patient Questionnaire (English) 
ABOUT YOUR TEST TODAY:
4 . The following questions are about your experience with HIV testing today . How true or 
false are the following statements?
Definitely 
true
Mostly true
Neither true 
nor untrue
Mostly false
Definitely 
false
A. I had a choice to take the test. 1 2 3 4 5
B. My HIV test was done in private. 1 2 3 4 5
IF YOU WERE TESTED TODAY:
C. I was satisfied with the amount of 
time it took to receive my results. 1 2 3 4 5
ABOUT WRITTEN MATERIALS YOU MAY HAVE RECEIVED:
5 . Did you receive materials to read about HIV or HIV testing today?
  Yes
  No
6 . How true of false are the following statements about the materials you received, 
if any?
Definitely 
true
Mostly true
Neither true 
nor untrue
Mostly false
Definitely 
false
A. I could understand the 
information I was given about 
taking an HIV test
1 2 3 4 5
B. The materials I received explained 
how to get or give HIV. 1 2 3 4 5
C. I had had a chance to ask 
questions about the materials I 
received.
1 2 3 4 5
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ABOUT YOUR HEALTH CARE PROVIDERS:
The following questions are about your health care providers.
7 . Rate your level of agreement with the following statements about your health care 
providers .
Totally 
Disagree
Somewhat 
Disagree
Neither 
Agree nor 
Disagree
Somewhat 
Agree
Totally 
Agree
A. My healthcare providers think 
people with HIV sleep with a lot 
of different people.
1 2 3 4 5
B. My health care providers avoid 
caring for patients with HIV. 1 2 3 4 5
C. My health care providers think 
people with HIV are gay. 1 2 3 4 5
D. My health care providers don’t 
want to treat people with HIV. 1 2 3 4 5
E. My health care providers are 
uncomfortable caring for patients 
with HIV.
1 2 3 4 5
F. My health care providers think 
people with HIV use drugs. 1 2 3 4 5
G. My health care providers treat 
people with HIV like they are not 
as good as other people.
1 2 3 4 5
OVERALL EXPERIENCE:
8 . Overall, how would you rate your experience with HIV testing today?
  Poor
  Fair
  Good
  Very Good
  Excellent
  Don’t know
ABOUT YOUR HIV RISK
The next questions are about whether you think you are at risk or may be at risk of getting HIV. If 
you are HIV positive, please skip this section and go to Question 16. We are asking these questions 
to learn about risks for HIV in our community. Your answers are completely anonymous and will 
never be linked to you.
9 . Do you feel that you are at risk for HIV?
  Yes
  No
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10 . Approximately how many different sexual partners (vaginal or anal sex) have you had in 
the past year? ____ (If ‘0’, please skip to Question 12)
11 . In the last year, have you had either vaginal or anal sex with: (Check all that apply)
  Men
 Women
  Transgender (Male-to-Female)
  Transgender (Female-to-Male)
12 . Have you ever been in jail?
  Yes
  No
13 . Have you ever used a needle to inject street drugs?
  Yes
  No
14 . Have you ever exchanged sex for money or drugs?
  Yes
  No
15 . Have you ever had a sexually transmitted disease (STD) such as syphilis, chlamydia, 
gonorrhea, herpes, or genital warts?
  Yes
  No
ABOUT YOUR EXPERIENCE WITH HIV TESTING:
These next two questions are about your past experience with HIV testing.
16 . Before today, when was the last time you had an HIV test?
 Within the past 12 months
  More than 12 months ago
  I have never had an HIV test before today
17 . Before today, how many times have you been tested for HIV?_________
17a . What was the result of your last test?
  Negative
  Positive (‘reactive’ test)
  I never received the results
  Invalid and/or Indeterminate
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DEMOGRAPHICS:
Now we would like to ask you some things that will help us know more about you.
18 . How old are you? _______
19 . Are you:
  Male
  Female
  Transgender (Male-to-Female)
  Transgender (Female-to-Male)
20 . Do you consider yourself Hispanic or Latino/a?
  Yes
  No
21 . What is your race? (Check all that apply)
  American Indian/Alaskan Native
  Asian
  Black/African American
  Native Hawaiian/Pacific Islander
 White, not of Hispanic origin
  Another race
  Don’t know
22 . What is the highest education level you have completed?
  Did not complete high school
  High school graduate, GED, or equivalent
  Some college
  College degree or higher
  Don’t know
23 . What kind/s of health insurance do you have now? (Check all that apply .)
  Medicaid
  Medicare
  Veteran’s administration
  Private insurance or HMO (i.e. Blue Cross, Kaiser, etc.)
  None
  Other (describe):_____________________________
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24 . Describe your current relationship status (Check one)
  Single / Never married
  In a committed relationship, but not married
  Married
  Separated
  Divorced
 Widowed
  Other (describe):_____________________________
  Don’t know
25 . Describe your sexual orientation: (Choose one)
  Straight/Heterosexual
  Gay/Homosexual
  Bisexual
  Not sure
  Other (describe):_____________________________
You have completed the questionnaire. Thank you for your time!
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Appendix B2 — Patient Questionnaire (Spanish)
Evaluación No ___________
Evaluación para pacientes sobre la prueba del VIH
Esta evaluación es completamente anónima (o sea que no se usará su nombre) y su participación 
es voluntaria. Usted puede dejar de contestar cualquier pre-gunta y puede saltar se esas preguntas 
que no desee contestar. Gracias por su tiempo.
1 . ¿Se hizo hoy la prueba del VIH?
  Sí
  No
Si NO SE HIZO hoy la prueba del VIH, ¿Por qué no se la hizo? Marque todo lo que se aplique 
  Nadie me preguntó sobre eso
  No creo estar en riego de estar infectado/a con el VIH
  Me hice la prueba del VIH recientemente
  Ya soy VIH positivo/a (if selected, skip out of question 9)
  Me preocupa la confidencialidad
  No quiero que se me haga la prueba en esta clínica
  Tengo miedo de averiguar que soy VIH positivo/a
  Tengo miedo de que me pinchen el dedo/ o de las agujas
  Otro (describa):_____________________________
Si usted SE HIZO hoy la prueba del VIH, ¿Cuál fue el resultado de su prue-ba?
  Negativo
  Positivo
  Preliminar positivo
  Inválido o indeterminado.
  Regresaré a buscar los resultados en otra visita
  Alguien me llamará con los resultados
  No sé
Si el resultado de la prueba fue negativo, ¿Piensa que se hará otra prueba en el futuro?
  Si
  No
  No sé
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2 . ¿Qué tanto afectó lo siguiente su decisión de hacerse hoy la prueba del VIH?
Nada Un poco
Una 
cantidad 
moderada
Bastante Mucho
A. Me preocupaba averiguar el 
resultado de mi prueba del VIH. 1 2 3 4 5
B. Me preocupaba que alguien más 
se enterara de mi estatus del VIH. 1 2 3 4 5
C. Sentí que debía hacerme la 
prueba del VIH. 1 2 3 4 5
D. Me preocupaba poder conseguir 
aseguranza médica o seguro de 
vida si averiguaba que tenía VIH.
1 2 3 4 5
E. No sabía cuánto tiempo llevaría 
hacerme la prueba. 1 2 3 4 5
F. No sabía cuánto tiempo llevaría 
recibir los resultados de mi 
prueba.
1 2 3 4 5
G. Me preocupaban más otras 
cuestiones relacionadas con mi 
salud. 
1 2 3 4 5
SOBRE LA PRUEBA DEL VIH EN GENERAL
3 . Para usted, ¿Qué tan importantes son los siguientes procedimientos relacio-nados con la 
prueba del VIH?
Para nada 
importantes
Un poco 
importantes
Modera-
damente 
importantes
Muy im-
portantes
Extrema-
damente 
importantes
A. Tener la oportunidad de dar 
permiso por escrito para hacerme 
la prueba.
1 2 3 4 5
B. La prueba del VIH es 
completamente privada. 1 2 3 4 5
C. La prueba del VIH se provee gratis. 1 2 3 4 5
D. No tengo que pedir hacerme la 
prueba del VIH porque la prueba 
del VIH es parte regular de la 
atención médica.
1 2 3 4 5
E. Se me dio la oportunidad de decir 
“no” en relación con hacerme la 
prueba.
1 2 3 4 5
F. Puedo recibir los resultados de mi 
prueba hoy mismo. 1 2 3 4 5
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SOBRE SU PRUEBA DEL DÍA DE HOY
4 . Las siguientes preguntas son acerca de su experiencia con la prueba del VIH en el día de 
hoy, ¿Qué tan verdaderas o falsas son las frases siguientes?
Defini-
tivamente 
verdadera
Verdade 
ra en su 
mayoría
Ni verdade-
ra ni falsa
Falsa en su 
mayoría
Definitiva-
mente falsa
A. Pude elegir si hacerme la prueba 
o no. 1 2 3 4 5
B. La prueba del VIH se me hizo en 
privado. 1 2 3 4 5
SI SE HIZO LA PRUEBA HOY
C. Estuve satisfecho/a con la 
cantidad de tiempo que llevó 
recibir mis resultados
1 2 3 4 5
SOBRE LOS MATERIALES ESCRITOS QUE PUEDE HABER RECIBIDO
5 . ¿Recibió hoy algún material para leer acerca del VIH o sobre la prueba del VIH?
  Si
  No
6 . ¿Qué tan verdaderas o falsas son las frases siguientes sobre los materiales que recibió, si 
es que los recibió?
Defini-
tivamente 
verdadera
Verdade 
ra en su 
mayoría
Ni verdade-
ra ni falsa
Falsa en su 
mayoría
Definitiva-
mente falsa
A. Pude entender la información 
que se me dio sobre hacerme la 
prueba del VIH.
1 2 3 4 5
B. Los materiales que recibí 
explicaban cómo contagiarse el 
VIH o cómo transmitir el VIH a 
otras personas.
1 2 3 4 5
C. Tuve la opotunidad de hacer 
preguntas acerca de los 
materiales que recibí.
1 2 3 4 5
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SOBRE SUS PROVEEDORES DE LA SALUD:
Las siguientes frases son acerca de sus proveedores de atención de la salud.
7 . Califique su nivel de acuerdo con las siguientes frases acerca de sus proveedores de 
atención de la salud .
Totalmente 
en desa-
cuerdo
Algo en 
desacuerdo
Ni de acu-
erdo ni en 
desacerdo
Algo de 
acuerdo
Totalmente 
de acuerdo
A. Mis proveedores de la salud 
piensan que las personas con  
VIH se acuestan con muchas 
personas distintas.
1 2 3 4 5
B. Mis proveedores de la salud evitan 
atender a pacientes con VIH. 1 2 3 4 5
C. Mis proveedores de la salud 
piensan que las personas con VIH 
son gay.
1 2 3 4 5
D. Mis proveedores de la salud no 
quieren atender a personas con 
VIH.
1 2 3 4 5
E. Mis proveedores de la salud no 
se sienten cómodos atendiendo a 
pacientes con VIH.
1 2 3 4 5
F. Mis proveedores de la salud 
piensan que las personas con VIH 
usan drogas.
1 2 3 4 5
G. Mis proveedores de la salud tratan 
a las personas con VIH como si 
fueran menos que otras personas.
1 2 3 4 5
EXPERIENCIA EN GENERAL:
8 . En general ¿Cómo calificaría su experiencia de hoy relacionada con la prueba del VIH?
  Pobre
  Regular
  Buena
  Muy buena
  Excelente
  No sé
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SOBRE SU RIESGO PARA EL VIH
Las próximas preguntas son acerca de si usted está en riesgo para el VIH o podría estar en riesgo 
del VIH. Le hacemos estas preguntas para conocer más acerca de los riesgos para el VIH en nuestra 
comunidad. Sus respuestas son completamente anó-nimas y nunca podrán ser vinculadas con 
usted.
9 . ¿Siente usted que está a riesgo de contraer VIH?
  Sí
  No
10 . ¿Aproximadamente cuántas parejas sexuales (sexo vaginal o anal) tuvo usted en el último 
año? ________ (Si ‘0’, por favor pase a la pregunta 12)
11 . Durante el último año, ¿Ha tenido sexo vaginal o anal con? (Marque todo lo que se aplique)
  Hombres
  Mujeres
  Personas transgénero (de hombre a mujer)
  Personas transgénero (de mujer a hombre)
12 . ¿Alguna vez ha estado usted en la cárcel?
  Sí
  No
13 . ¿Alguna vez ha usado usted una aguja para inyectarse drogas que se consiguen en la calle?
  Sí
  No
14 . ¿Alguna vez ha intercambiado usted sexo por dinero o drogas?
  Sí
  No
15 . ¿Ha tenido una enfermedad transmitida sexualmente (ETS) como sífilis, clamidia, gonorrea, 
herpes, o verrugas genitales?
  Sí
  No
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SOBRE SU EXPERIENCIA CON LA PRUEBA DEL VIH
Las próximas dos preguntas son acerca de su experiencia anterior con la prueba del VIH.
16 . Antes de hoy ¿Cuándo fue la última vez que se hizo la prueba del VIH?
  En los últimos 12 meses
  Más de 12 meses atrás
  Nunca me había hecho la prueba del VIH antes de hoy
17 . Antes de hoy ¿Cuántas veces se había hecho la prueba del VIH?________
17a . ¿Cuál fue el resultado de su última prueba?
  Negativo
  Positivo 
  Preliminar positivo
  Nunca recibí los resultados
  Inválido y/o indeterminado 
DATOS DEMÓGRAFICOS:
Ahora nos gustaría preguntarle algunas cosas que nos ayudarán a saber más sobre usted.
18 . ¿Qué edad tiene usted? _______
19 . ¿Es usted?
  Hombre
  Mujer
  Persona transgénero (de hombre a mujer)
  Persona transgénero (de mujer a hombre)
20 . ¿Se considera usted Hispano(a) o Latino(a)?
  Sí
  No
21 . ¿Cuál es su raza? (marque todo lo que se aplique)
  Indígena Americano(a)/Nativo(a) de Alaska
  Asiático(a)
  Negro(a)/Africano Americano(a)
  Nativo(a) de Hawai/de las islas del Pacífico 
  Blanco(a), no Hispano(a)
  Otro grupo étnico
  No sé
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22 . ¿Cuál es el nivel de educación más alto que ha completado?
  Escuela secundaria no completa
  Título de escuela secundaria, GED, o equivalente
  Algo de universidad
  Título universitario o nivel más alto
  No sé
23 . ¿Qué tipo(s) de seguro médico tiene actualmente? (Marque todo lo que se aplique)
  Medicaid
  Medicare
  Administración para Veteranos
  Seguro Médico Privado o HMO (ejemplo: Blue Cross, Kaiser)
  Ninguno
  Otro (describa): __________________________
24 . Describa su estado civil (Elija uno)
  Soltero(a), no casado(a)
  En una relación estable, pero no casado(a)
  Casado(a)
  Separado(a)
  Divorciado(a)
  Viudo(a)
  Otro (describa): __________________________
25 . Describa su orientación sexual: (Elija una)
  Heterosexual
  Gay/Homosexual
  Bisexual
  No está seguro(a)
  Otro(describa): __________________________
Usted ha completado el cuestionario. ¡Gracias por su tiempo!
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Appendix C — Provider Assessment
Questionnaire ID Number____________
Questionnaire for Health Care Providers and Staff
Instructions:
This survey is being done to obtain the perspectives of health care providers and staff about routine 
HIV testing and patients’ satisfaction with the testing process. This is being done in conjunction 
with a Patient Questionnaire. We would like to know what you think about the implementation 
of routine HIV testing in your health care setting to help us know whether we are meeting patients’ 
needs and to help us improve these services. This survey is completely anonymous (your name will 
not be used) and your participation is voluntary. You can skip any questions that you don’t want 
to answer. The questionnaire will take about 10 minutes to complete. Thank you for your time.
Section A . 
Please complete the following questions .
1 . What is your primary profession or role? (Check one response)
  Case Manager
  Manager/Administrator
  Front Desk Clerk/Receptionist
  HIV Counselor
  Lab Technician
  Nurse
  Nurse Practitioner
  Nursing Assistant
  Phlebotomist
  Physician
  Resident Physician
  Physician Assistant
  Psychologist
  Social Worker
  Other ___________________________
2 . What is your role in routine HIV testing? (Check all that apply)
  Management or administrative role in routine HIV testing
  Supervise staff conducting HIV testing
  Conduct HIV testing
  Provide health care services for patients who have received routine HIV testing/screening
  Teach other health care providers or students about routine HIV testing
  No role in routine HIV testing
  Other (Specify) __________________________________________________________
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Section B . 
Circle one response for each of the following items that best describes your personal 
perspectives about routine HIV testing in your work setting .
Strongly 
Disagree
Disagree
Neither 
Agree or 
Disagree
Agree
Strongly 
Agree
Don’t 
Know
Not Ap-
plicable 
(NA)
1. I think routine HIV testing 
is an important part of 
regular health care.
1 2 3 4 5
Don’t 
Know
NA
2. I am concerned about 
cost and reimbursement 
for HIV testing. 
1 2 3 4 5
Don’t 
Know 
NA
3. I am concerned that 
patients will be offended 
by being offered routine 
HIV testing.
1 2 3 4 5
Don’t 
Know
NA
4. I am comfortable 
discussing routine HIV 
testing with patients. 
1 2 3 4 5
Don’t 
Know
NA
5. Language barriers 
prevent some patients 
from receiving routine 
HIV testing.
1 2 3 4 5
Don’t 
Know
NA
6. Patients often feel like 
they have to accept 
routine HIV testing.
1 2 3 4 5
Don’t 
Know
NA
7. Patients receive adequate 
pre-test information for 
routine HIV testing.
1 2 3 4 5
Don’t 
Know
NA
8. Patients receive adequate 
post-test information for 
routine HIV testing.
1 2 3 4 5
Don’t 
Know
NA
9. Patients are concerned 
about the confidentiality 
of routine HIV testing.
1 2 3 4 5
Don’t 
Know
NA
10. Routine HIV testing is 
voluntary; patients are 
able to decline screening.
1 2 3 4 5
Don’t 
Know
NA
11. Patients do not expect 
to be offered routine HIV 
testing.
1 2 3 4 5
Don’t 
Know
NA
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12. I am concerned that 
routine HIV testing will 
have a negative effect on 
patients’ opinions about 
our [health care facility/
clinic/emergency depart-
ment/practice]. 
1 2 3 4 5
Don’t 
Know
NA
13. We have the resources 
needed to implement 
routine HIV testing. 
1 2 3 4 5
Don’t 
Know
NA
14. It is difficult to provide 
the privacy needed for 
routine HIV testing.
1 2 3 4 5
Don’t 
Know
NA
Section C . 
Circle one response for each of the following items that best describes your personal 
perspectives about routine HIV testing in your work setting . Please note that the response 
scale has changed .
Never Rarely
About 
half the 
time
Most of 
the time
Almost 
always 
or 
Always
Don’t 
Know
Not Ap-
plicable 
(NA)
1. Routine HIV testing 
interferes with providing 
other health care services.
1 2 3  4 5
Don’t 
Know
NA
2. Patients are given HIV test 
results in a confidential, 
appropriate manner.
1 2 3 4 5
Don’t 
Know
NA
3. Results of routine HIV 
testing are documented 
and available to health 
care providers taking care 
of the patient.
1 2 3 4 5
Don’t 
Know
NA
4. Patients are concerned 
or upset by routine HIV 
testing.
1 2 3 4 5
Don’t 
Know
NA
5. The presence of family 
members and visitors 
makes it difficult to 
discuss routine HIV 
testing with patients.
1 2 3 4 5
Don’t 
Know
NA
6. Patients understand the 
information they receive 
about routine HIV testing.
1 2 3 4 5
Don’t 
Know
NA
7. Patients who test 
HIV positive receive 
appropriate referrals for 
follow up
1 2 3 4 5
Don’t 
Know
NA
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Section D .
1 . List any benefits or positive outcomes that have resulted from the implementation of 
routine HIV testing in your work setting .
 ______________________________________________________________________________________  
 ______________________________________________________________________________________  
 ______________________________________________________________________________________
2 . List any problems or negative outcomes that have resulted from the implementation of 
routine HIV testing in your work setting .
 ______________________________________________________________________________________  
 ______________________________________________________________________________________  
 ______________________________________________________________________________________
3 . Share any other comments about this questionnaire or about the implementation of 
routine HIV testing in your work setting .
 ______________________________________________________________________________________  
 ______________________________________________________________________________________  
 ______________________________________________________________________________________
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